Printer Friendly

TEXAS BIOTECHNOLOGY OVER-ALLOTMENT OPTION EXERCISED

 HOUSTON, Jan. 6 /PRNewswire/ -- Texas Biotechnology Corporation (AMEX: TXB.E) today announced that D. Blech & Co. has exercised the option to offer an over-allotment of 532,500 Units. This announcement follows the recent completion of its initial public offering (IPO) last month of 3,550,000 Units representing one share of common stock and one redeemable common stock purchase warrant.
 The TBC offering was managed by D. Blech & Company, Inc. Trading of TBC's common shares commenced Dec. 16, on the American Stock Exchange under the ticker symbol "TXB.E." Copies of the final prospectus relating to the public offering may be obtained from D. Blech & Company, Inc., Prospectus Department 800-669-4351.
 Texas Biotechnology Corporation, a biopharmaceutical company, applies innovative drug discovery techniques and its specialized knowledge of the role of vascular cell biology in cardiovascular disease to the design and development of novel pharmaceutical compounds. The company's research and development programs focus on the development of small molecule drugs that prevent blood clot formation (thrombosis), the proliferation of smooth muscle cells at sites of vessel injury (vascular proliferative disease), and inflammatory responses to vessel injury (vascular inflammation).
 -0- 1/6/94
 /CONTACT: David B. McWilliams, president and CEO, or Stephen L. Mueller, director - finance and administration of Texas Biotechnology, 713-796-8822; or Anthony J. Russo, Ph.D., of Noonan/Russo Communications, 212-696-4455 ext. 202/
 (TXB.E)


CO: Texas Biotechnology Corporation ST: Texas IN: MTC SU:

MP-SP -- NY056 -- 7004 01/06/94 12:28 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 6, 1994
Words:242
Previous Article:MACUSA BECOMES SALES AGENT FOR MIRROR TECHNOLOGIES, WILL PURCHASE KEY ASSETS; MIRROR EXITING BUSINESS
Next Article:SHOPPERS CHARGE ACCOUNTS CO. REPORTS 7.9% INCREASE IN HOLIDAY SALES FOR SPECIALTY RETAILERS IN ITS PRIVATE LABEL CREDIT CARD PROGRAM
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters